SG11201505222RA - Fasting levels of growth hormone as a predictive marker of cardiovascular risk - Google Patents
Fasting levels of growth hormone as a predictive marker of cardiovascular riskInfo
- Publication number
- SG11201505222RA SG11201505222RA SG11201505222RA SG11201505222RA SG11201505222RA SG 11201505222R A SG11201505222R A SG 11201505222RA SG 11201505222R A SG11201505222R A SG 11201505222RA SG 11201505222R A SG11201505222R A SG 11201505222RA SG 11201505222R A SG11201505222R A SG 11201505222RA
- Authority
- SG
- Singapore
- Prior art keywords
- growth hormone
- cardiovascular risk
- predictive marker
- fasting levels
- fasting
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 239000003550 marker Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/61—Growth hormones [GH] (Somatotropin)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13150566 | 2013-01-08 | ||
| PCT/EP2014/050143 WO2014108396A1 (en) | 2013-01-08 | 2014-01-07 | Fasting levels of growth hormone as a predictive marker of cardiovascular risk |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201505222RA true SG11201505222RA (en) | 2015-08-28 |
Family
ID=47469834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201505222RA SG11201505222RA (en) | 2013-01-08 | 2014-01-07 | Fasting levels of growth hormone as a predictive marker of cardiovascular risk |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20150346222A1 (de) |
| EP (1) | EP2943795B1 (de) |
| JP (1) | JP6430962B2 (de) |
| CN (2) | CN104937421B (de) |
| CA (1) | CA2897327A1 (de) |
| ES (1) | ES2879023T3 (de) |
| HK (2) | HK1215302A1 (de) |
| RU (1) | RU2677895C2 (de) |
| SG (1) | SG11201505222RA (de) |
| WO (1) | WO2014108396A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3201631B1 (de) * | 2014-10-01 | 2021-05-26 | SphingoTec GmbH | Hgh-bestimmung zur verwendung bei der führung der prävention eines unerwünschten schweren herzereignisses oder einer herz-kreislauf-erkrankung bei einer person |
| US9921230B2 (en) * | 2014-10-08 | 2018-03-20 | Rhode Island Hospital | Methods for diagnosis and treatment of concussion or brain injury |
| CA3012985A1 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
| EP3577462B1 (de) * | 2017-02-06 | 2024-04-17 | Resiliun B.V. | Wechselwirkung zwischen c-peptiden und elastin-rezeptor, ein modell zum verständnis der gefässerkrankung |
| RU2770550C1 (ru) * | 2021-05-31 | 2022-04-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ прогнозирования сердечно-сосудистого риска с помощью определения уровня эстрогенов |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU634716B2 (en) | 1988-08-01 | 1993-03-04 | Ciba Corning Diagnostics Corp. | Method for detection of an analyte using acridinium esters and liposomes |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| EP1427750B1 (de) | 2001-08-30 | 2010-12-08 | Biorexis Pharmaceutical Corporation | Modifizierte transferrin-fusionsproteine |
| DK1531791T3 (da) | 2002-06-07 | 2010-11-01 | Dyax Corp | Forebyggelse og begrænsning af iskæmi |
| EP1684786A4 (de) * | 2003-10-24 | 2007-12-12 | Merck & Co Inc | Verbessertung der spiegel des wachstumshormons mit einem dipeptidyl-peptidase-iv-hemmer und einem wachstumshormon-sekretagog |
| US20050164301A1 (en) | 2003-10-24 | 2005-07-28 | Avidia Research Institute | LDL receptor class A and EGF domain monomers and multimers |
| US20100028995A1 (en) | 2004-02-23 | 2010-02-04 | Anaphore, Inc. | Tetranectin Trimerizing Polypeptides |
| WO2006032436A2 (en) | 2004-09-21 | 2006-03-30 | Nascacell Technologies Ag. | Use of microproteins as tryptase inhibitors |
| WO2007124439A2 (en) * | 2006-04-21 | 2007-11-01 | Rules-Based Medicine, Inc. | Diagnosis of stroke using metalloproteinase or transaminase |
| WO2009077175A1 (en) | 2007-12-19 | 2009-06-25 | Affibody Ab | Polypeptide derived from protein a and able to bind pdgf |
| ES2724478T3 (es) * | 2008-10-24 | 2019-09-11 | Brahms Gmbh | Pronóstico y evaluación del riesgo en pacientes con accidente cerebrovascular determinando el nivel de péptidos marcadores |
| DK2358746T3 (da) | 2008-11-03 | 2020-12-21 | Molecular Partners Ag | Bindingsproteiner til inhibering af vegf-a-receptorinteraktionen |
| BR112012004314A2 (pt) | 2009-08-27 | 2016-11-29 | Covagen Ag | compostos de ligação a il-17 e usos medicinais desses compostos |
| EP2513138B1 (de) | 2009-12-14 | 2014-10-01 | Scil Proteins GmbH | Modifizierte ubiquitin-proteine mit spezifischer bindungsaktivität für die extradomäne b von fibronectin |
| AU2011263786B2 (en) | 2010-06-08 | 2014-11-13 | Astrazeneca Ab | Tear lipocalin muteins binding IL-4 R alpha |
-
2014
- 2014-01-07 CA CA2897327A patent/CA2897327A1/en not_active Abandoned
- 2014-01-07 RU RU2015133018A patent/RU2677895C2/ru active
- 2014-01-07 JP JP2015552040A patent/JP6430962B2/ja active Active
- 2014-01-07 EP EP14700090.5A patent/EP2943795B1/de active Active
- 2014-01-07 CN CN201480004097.1A patent/CN104937421B/zh active Active
- 2014-01-07 ES ES14700090T patent/ES2879023T3/es active Active
- 2014-01-07 SG SG11201505222RA patent/SG11201505222RA/en unknown
- 2014-01-07 US US14/759,487 patent/US20150346222A1/en not_active Abandoned
- 2014-01-07 WO PCT/EP2014/050143 patent/WO2014108396A1/en active Application Filing
- 2014-01-07 CN CN201711342047.6A patent/CN107991501A/zh active Pending
-
2016
- 2016-03-21 HK HK16103237.9A patent/HK1215302A1/zh unknown
-
2018
- 2018-11-01 HK HK18113968.1A patent/HK1254867A1/zh unknown
-
2019
- 2019-10-10 US US16/598,401 patent/US20200049721A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2015133018A (ru) | 2017-02-14 |
| CN104937421B (zh) | 2018-01-19 |
| CN107991501A (zh) | 2018-05-04 |
| ES2879023T3 (es) | 2021-11-19 |
| RU2677895C2 (ru) | 2019-01-22 |
| CN104937421A (zh) | 2015-09-23 |
| US20200049721A1 (en) | 2020-02-13 |
| HK1254867A1 (zh) | 2019-07-26 |
| HK1215302A1 (zh) | 2016-08-19 |
| JP2016507743A (ja) | 2016-03-10 |
| EP2943795A1 (de) | 2015-11-18 |
| CA2897327A1 (en) | 2014-07-17 |
| US20150346222A1 (en) | 2015-12-03 |
| JP6430962B2 (ja) | 2018-11-28 |
| WO2014108396A1 (en) | 2014-07-17 |
| EP2943795B1 (de) | 2021-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1203783A1 (zh) | 鞋帶卷取用卷盤 | |
| HK1222860A1 (zh) | 作爲葛瑞林 -酰基轉移酶抑制劑的被取代的哌啶基-乙基-嘧啶 | |
| HK1254867A1 (zh) | 生長激素的禁食水平作為心血管風險的預測標誌物 | |
| LT3003866T (lt) | Dozatoriaus gamybos būdas | |
| HK1218728A1 (zh) | 抑制骨質疏鬆的治療劑 | |
| GB2535880B (en) | Two-part set-delayed cement compositions | |
| GB2515071B (en) | Novel composition for a foot-soaking bath | |
| HRP20180722T1 (hr) | Spoj benzotiofena | |
| ZA201504931B (en) | New antifungal compositions | |
| IL230063A0 (en) | A technique to control selection order | |
| GB201308321D0 (en) | Top marker | |
| GB201300524D0 (en) | Method of manufacture of a container | |
| GB2511764B (en) | Pole for show jumping | |
| AU2013245V (en) | Bondrelaipi Xerochrysum bracteatum | |
| AU2013244V (en) | Bondrepuho Xerochrysum bracteatum | |
| AU2013243V (en) | Bondreredem Xerochrysum bracteatum | |
| GB201312761D0 (en) | A composition | |
| GB201311648D0 (en) | A novel glass-lonomer cement | |
| GB201314389D0 (en) | Novel target | |
| GB201314379D0 (en) | Novel target | |
| GB201308441D0 (en) | Automatic placement markers |